0
0
For decades, the dramatic “growth spurt” of puberty has been viewed as a biological mystery of timing and hormones. While doctors knew that growth hormone acted as the fuel, they were less certain about the identity of the engine it was powering. Now, a landmark study led by researchers at the University of Gothenburg in Sweden has identified the “engine” for the first time: two previously unknown types of stem-like cells nestled within the human growth plate.
The research, published in Science Translational Medicine, provides a high-resolution map of how children grow taller and confirms that growth hormone targets these specific cells directly. This discovery challenges long-standing assumptions in pediatric endocrinology and paves the way for more precise treatments for children with growth disorders.
Mapping the Human Growth Plate
Height is determined at the growth plates—specialized areas of cartilage located near the ends of long bones, such as the femur (thigh bone) and tibia (shin bone). As these plates produce new cartilage, that cartilage eventually mineralizes into hard bone, extending the length of the skeleton.
To understand this process at a molecular level, the Gothenburg team, led by researcher Nelson Tsz Long Chu and Professor Andrei Chagin, analyzed surgical growth-plate tissue from children undergoing orthopedic procedures. Using advanced single-cell and spatial transcriptomics—technologies that allow scientists to see which genes are “turned on” in individual cells—the team created a first-of-its-kind “transcriptional atlas” of the pubertal human growth plate.
The Dual Stem-Cell System
The mapping uncovered a sophisticated dual-cell organization in the “resting zone” of the growth plate:
-
The Quiescent Pool: A “reserve” of stem cells that remain largely dormant. These cells act as a biological savings account, ensuring the body doesn’t run out of growth potential too early.
-
The Proliferative Pool: A more active group of stem cells that frequently divide to generate new cartilage cells (chondrocytes). These cells are the primary drivers of the day-to-day expansion of the skeleton.
“Our results show that growth hormone acts directly on the stem cells that are central to height growth,” says Nelson Tsz Long Chu, one of the study’s lead authors. “This may help us to develop more effective treatment strategies for children with short stature.”
How Growth Hormone “Talks” to Stem Cells
While growth hormone (GH) has been used as a therapy since the 1950s, the exact cellular pathways it uses in humans remained fuzzy. The Swedish study used human growth-plate explants—living tissue samples maintained in a lab—and exposed them to growth hormone.
The results were immediate and specific. The hormone directly activated several intracellular signaling cascades, most notably JAK/STAT, TGF-β, and ERK. Interestingly, the hormone simultaneously dampened AKT signaling. This complex balancing act tells the stem cells when to stay in reserve and when to start dividing rapidly.
This finding validates a theory first proposed by Gothenburg researchers forty years ago, which suggested GH worked directly on bone tissue rather than solely through intermediary signals from the liver.
Expert Perspectives and Public Health Implications
For the millions of families worldwide who utilize growth hormone therapy, this research offers a bridge toward “personalized” pediatric care. Currently, GH therapy is a “one-size-fits-most” approach, and response rates vary significantly between patients.
“This is a significant leap forward in our mechanistic understanding,” says Dr. Elena Rossi, a pediatric endocrinologist not involved in the study. “If we can identify biomarkers for these specific stem cell populations, we might eventually be able to predict which children will respond robustly to treatment and who might require a different therapeutic path.”
Potential Risks and Limitations
Despite the excitement, experts urge caution. The study relied on tissue from a small number of children undergoing surgery, which may not perfectly mirror the growth plates of the general population.
Furthermore, manipulating stem cells carries inherent risks. “Linear growth is a finite resource,” warns Dr. Rossi. “If you push these cells too hard, you might exhaust the reserve pool or accelerate growth-plate fusion. This could paradoxically shorten the total window a child has to grow, leading to a shorter adult height than intended.”
What This Means for Parents and Clinicians
For parents, the takeaway is one of biological respect: height growth is a tightly regulated, delicate process. This research underscores why “miracle” supplements or off-label use of hormones can be dangerous; interfering with the quiescent stem cell pool could have permanent skeletal consequences.
In the coming years, healthcare professionals may use these insights to:
-
Refine Dosing: Create more targeted hormone regimens that maximize proliferation without exhausting the stem cell “reserve.”
-
Improve Counseling: Better explain to families why growth therapy might slow down or stop as a child nears the end of puberty and their stem cell pools diminish.
As science moves closer to the “root” of human growth, the hope is that every child with a growth disorder can receive a treatment plan as unique as their own genetic map.
Medical Disclaimer
Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.
References
Study Citations:
-
Chu, N. T. L., et al. (2026). “A transcriptional atlas of the pubertal human growth plate reveals two populations of stem cells and direct effect of growth hormone.” Science Translational Medicine. DOI: 10.1126/scitranslmed.adw3590.
